These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 15554784

  • 1. Serotonin-1D hypothesis of obsessive-compulsive disorder: an update.
    Zohar J, Kennedy JL, Hollander E, Koran LM.
    J Clin Psychiatry; 2004; 65 Suppl 14():18-21. PubMed ID: 15554784
    [Abstract] [Full Text] [Related]

  • 2. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
    Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR.
    Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
    [Abstract] [Full Text] [Related]

  • 3. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL, Pigott TA.
    J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [Abstract] [Full Text] [Related]

  • 4. Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder.
    Koran LM, Pallanti S, Quercioli L.
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):169-72. PubMed ID: 11313163
    [Abstract] [Full Text] [Related]

  • 5. Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorder.
    Pian KL, Westenberg HG, van Megen HJ, den Boer JA.
    Psychopharmacology (Berl); 1998 Dec; 140(3):365-70. PubMed ID: 9877016
    [Abstract] [Full Text] [Related]

  • 6. [Psychobiology of compulsive disease].
    Lesch KP.
    Fortschr Neurol Psychiatr; 1991 Oct; 59(10):404-12. PubMed ID: 1761269
    [Abstract] [Full Text] [Related]

  • 7. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S, Harvey BH.
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [Abstract] [Full Text] [Related]

  • 8. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies.
    Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS.
    J Clin Psychiatry; 1992 Apr; 53 Suppl():17-28. PubMed ID: 1532961
    [Abstract] [Full Text] [Related]

  • 9. Zolmitriptan (a 5-HT1B/1D receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder.
    Boshuisen ML, den Boer JA.
    Psychopharmacology (Berl); 2000 Sep; 152(1):74-9. PubMed ID: 11041318
    [Abstract] [Full Text] [Related]

  • 10. Neuroendocrine challenge with a 5-HT(1D) receptor agonist differentiates between two subtypes of bipolar disorder according to polarity of onset.
    Mahmood T, Silverstone T.
    J Psychopharmacol; 2005 Jan; 19(1):109-10. PubMed ID: 15671138
    [No Abstract] [Full Text] [Related]

  • 11. 5-HT2c receptor activation induces grooming behaviour in rats: possible correlations with obsessive-compulsive disorder.
    Gráf M.
    Neuropsychopharmacol Hung; 2006 Mar; 8(1):23-8. PubMed ID: 16841562
    [Abstract] [Full Text] [Related]

  • 12. Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan.
    Gross-Isseroff R, Cohen R, Sasson Y, Voet H, Zohar J.
    Neuropsychobiology; 2004 Mar; 50(3):200-5. PubMed ID: 15365215
    [Abstract] [Full Text] [Related]

  • 13. Neurobiology of obsessive compulsive disorder: a possible role for serotonin.
    Winslow JT, Insel TR.
    J Clin Psychiatry; 1990 Aug; 51 Suppl():27-31; discussion 55-8. PubMed ID: 2199432
    [Abstract] [Full Text] [Related]

  • 14. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?
    Goodman WK, McDougle CJ, Price LH, Riddle MA, Pauls DL, Leckman JF.
    J Clin Psychiatry; 1990 Aug; 51 Suppl():36-43; discussion 55-8. PubMed ID: 2199433
    [Abstract] [Full Text] [Related]

  • 15. The effect of maternal ketanserin treatment on foetal 5-HT receptor function in umbilical cord artery of pre-eclamptic patients.
    Hanff LM, Gupta S, MaassenVanDenBrink A, Steegers EA, Saxena PR, Vulto AG, Visser W.
    Neonatology; 2007 Aug; 92(4):240-7. PubMed ID: 17556842
    [Abstract] [Full Text] [Related]

  • 16. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms.
    Ma N, Tan LW, Wang Q, Li ZX, Li LJ.
    Psychiatry Res; 2007 Feb 28; 150(1):61-9. PubMed ID: 17291595
    [Abstract] [Full Text] [Related]

  • 17. The serotonin-1Dbeta receptor gene and severity of obsessive-compulsive disorder in women with bulimia nervosa.
    Levitan RD, Kaplan AS, Masellis M, Basile VS, Richter MA, Kennedy JL.
    Eur Neuropsychopharmacol; 2006 Jan 28; 16(1):1-6. PubMed ID: 15944142
    [Abstract] [Full Text] [Related]

  • 18. Transmission disequilibrium analysis of the functional 5-HT3A receptor variant C178T in early-onset obsessive compulsive-disorder.
    Mössner R, Döring N, Scherag A, Schäfer H, Herpertz-Dahlmann B, Remschmidt H, Schulz E, Renner T, Wewetzer C, Warnke A, Lesch KP, Walitza S.
    J Psychopharmacol; 2007 Nov 28; 21(8):833-6. PubMed ID: 17259209
    [Abstract] [Full Text] [Related]

  • 19. Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin auto-receptor.
    Stein DJ, Van Heerden B, Wessels CJ, Van Kradenburg J, Warwick J, Wasserman HJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Aug 28; 23(6):1079-99. PubMed ID: 10621951
    [Abstract] [Full Text] [Related]

  • 20. Decision-making impairment is related to serotonin transporter promoter polymorphism in a sample of patients with obsessive-compulsive disorder.
    da Rocha FF, Malloy-Diniz L, Lage NV, Romano-Silva MA, de Marco LA, Correa H.
    Behav Brain Res; 2008 Dec 16; 195(1):159-63. PubMed ID: 18603313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.